Detection of numerical chromosome anomalies in interphase cells of ovarian carcinomas using fluorescence in situ hybridization

Genes Chromosomes and Cancer

Volumn 16, Issue 2, 1996, Pages 120-129

  Brock, Jo Ann K ^a   Liu, Wei Hua ^a   Smith, S Terrell ^a   Young, S Robert ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CENTROMERE; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 4; CHROMOSOME 6; CONTROLLED STUDY; DIPLOIDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERPHASE; NUMERICAL CHROMOSOME ABERRATION; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; X CHROMOSOME;

ADULT; AGED; AGED, 80 AND OVER; CENTROMERE; CHROMOSOME ABERRATIONS; DNA, SATELLITE; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 0029683118     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199606)16:2<120::AID-GCC6>3.0.CO;2-1     Document Type: Article

References (33)

1. Atkin NB, Baker MC (1987) Abnormal chromosomes including small metacentrics in 14 ovarian cancers. Cancer Genet Cytogenet 26:355-361.
2. Cliby W, Ritland S, Hartmann L, Dodson M, Hailing KC, Keeney G, Podratz KC, Jenkins RB (1993) Human epithelial ovarian cancer allelotype. Cancer Res 53:2393-2398.
3. Devilee P, Thierry RF, Kievitis T, Kolluri R, Hopman AHN, Willard HF, Pearson PL, Corneliesse CJ (1988) Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res 48:5825-5830.
4. DiSaia PJ, Creasman WT (1989) Clinical Gynecologic Oncology. St. Louis, Mosby Year Book.
5. Easton DF, Bishop D, Ford D, Crockford GP, the Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer. Am J Hum Genet 52:678-701.
6. Fitzgerald PH, McEwan CM (1977) Total aneuploidy and age-related sex chromosome aneuploidy in cultured lymphocytes of normal men and women. Hum Genet 39:329-337.
7. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Söderkvist P, Terry L, Jhanwar S, Berchuk A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122.
8. Galloway SM, Buckton KE (1978) Aneuploidy and ageing: Chromosome studies on a random sample of the population using G-banding. Cytogenet Cell Genet 20:78-95.
9. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancer. Science 253:49-53.
10. Jenkins RB, Bartelt D Jr, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L (1993) Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 71:76-86.
11. Kiechle-Schwartz M, Bauknecht T, Karck U, Kommoss F, duBois A, Pfleiderer A (1994) Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas. Gynecol Oncol 55:198-205.
12. Leone A, McBride OW, Wcston A, Wang MG, Anglard P, Cropp C, Goepel JR, Lidereau R, Callahan R, Linehan WM, Rees RC, Harris CC, Liotta LA, Steeg PS (1991a) Somatic allelic deletion of nm23 in human cancer. Cancer Res 51:2490-2493.
13. Leone A, Flatow U, King CR, Sandeen MA, Margulies IMK, Liotta LA, Steeg PS (1991b) Reduced tumor incidence, metastatic potential and cytokine responsive of nm23 transfected melanoma cells. Cell 65:25-35.
14. Liehr T, Stubinger A, Thoma K, Tulusan HA, Gebhart E (1994) Comparative interphase cytogenetics using FISH on human ovarian carcinomas. Anticancer Res 14:183-188.
15. McGowan JIJ, Speevak MD, Blakely D, Chevrette M (1994) Suppression of tumorigenicity in human teratocarcinoma cell line PA-1 by introduction of chromosome 4. Cancer Res 54:2568-2572.
16. Meisner LF, Han K, Lee W, Harris CP (1994) Assessing aneuploidy in normal tissues with FISH: Pitfalls and insights. Cancer Genet Cytogenet 72:78-80.
17. Merajver SD, Pham T, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS (1995) Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet 9:439-443.
18. Miki Y, Swenson J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Navod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-72.
19. Nederlof PM, vanderFlier S, Rapp AK, Tanke HJ, vanderPloeg M, Kornips F, Geraedts J (1989) Detection of chromosome aberrations in interphase tumor nuclei by non-radioactive in situ hybridization. Cancer Genet Cytogenet 42:87-98.
20. Pejovic T, Heim S, Mandahl N, Elmfors B, Floderus UM, Furgyik S, Helm G, Willen H, Mitelman F (1990) Trisomy 12 is a consistent chromosome aberration in benign ovarian tumors. Genes Chromosom Cancer 2:48-52.
21. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfohrs B, Floderus U, Furgyik S, Helm G, Himmelmann A, Willen H, Mitelman F (1992) Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosom Cancer 4:58-68.
22. Persons DL, Hartmann LC, Herath JF, Borell TJ, Cliby WA, Keeney GL, Jenkins RB (1993) Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol 142:733-741.
23. Pinkel D, Straume T, Gray JW (1986) Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83:2934-2938.
24. Roberts CG, Tattersall MHN (1990) Cytogenetic study of solid ovarian tumors. Cancer Genet Cytogenet 48:243-253.
25. Saito H, Inazawa J, Saito S, Kasumi F, Koi S, Sagae S, Kudo R, Saito J, Noda K, Nakamura Y (1993) Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 53: 3382-3385.
26. Sandberg AA (1990) The Chromosomes in Human Cancer and Leukemia, 2nd ed. New York: Elsevier Science, pp 839-846.
27. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y (1991) Allelotype of human ovarian cancer. Cancer Res 51:5118-5122.
28. Tanaka K, Boice CR, Testa JR (1989) Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet 43: 1-14.
29. Taruscio D, Carcangiu ML, Reid T, Ward DC (1994) Numerical chromosome aberrations in thyroid tumors detected by double fluorescence in situ hybridization. Genes Chromosom Cancer 9:180-189.
30. Tavassoli M, Ruhrberg C, Beaumont V, Reynolds K, Kirkham N, Collins WP, Farzaneh F (1993) Whole chromosome 17 loss in ovarian cancer. Genes Chromosom Cancer 8:195-198.
31. Thompson FH, Liu Y, Emerson J, Weinstein R, Makar R, Trent JM, Taetle R, Alberts DS (1994) Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma. Genes Chromosom Cancer 10:262-266.
32. Trent JM (1985) Prevalence and clinical significance of cytogenetic abnormalities in ovarian cancer. In Alberts DS, Surwit EA (eds): Ovarian Cancer. New York: Martinus Nijhoff pp 1-21.
33. Wake N, Myroslaw M, Hreshchyshyn M, Piver SM, Matsui S, Sandberg AA (1980) Specific cytogenetic changes in ovarian cancer involving chromosome 6 and 14. Cancer Res 40:4512-4518.